CIA
SGHT icon

Concurrent Investment Advisors’s Sight Sciences SGHT Stock Holding History

Concurrent Investment Advisors’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-42,252
Closed -$266K – 1206
2024
Q3 		$266K Hold
42,252
– – 0.01% 825
2024
Q2 		$282K Hold
42,252
– – 0.01% 761
2024
Q1 		$223K Hold
42,252
– – 0.01% 766
2023
Q4 		$218K Buy
+42,252
New +$130K 0.01% 743

Other funds holding SGHT

JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

Concurrent Investment Advisors's SGHT Position: Q4 2024 in Review

Concurrent Investment Advisors sold out of Sight Sciences (SGHT) in Q4 2024, closing a stake of 42,252 shares — an estimated $266K sold.

Concurrent Investment Advisors first reported a position in SGHT in Q4 2023 and held it in 4 quarters. The position peaked at $282K in Q2 2024. 83 funds tracked by Wall St. Rank hold SGHT as of Q4 2024.

  • Concurrent Investment Advisors reported no remaining Sight Sciences position as of Q4 2024 after selling out during the quarter.
  • Concurrent Investment Advisors sold 42,252 Sight Sciences shares in Q4 2024, an estimated $266K.
  • Concurrent Investment Advisors first reported a position in Sight Sciences in Q4 2023 and held it in 4 quarters.
  • Concurrent Investment Advisors's Sight Sciences position peaked at $282K in Q2 2024.
  • 83 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2024.

Based on Concurrent Investment Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.